Zobrazeno 1 - 10 of 55 pro vyhledávání: '"Sophie Gourgou Bourgade"'
1
Akademický článek
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
Autor: Aurélien Lambert, Marta Jarlier, Sophie Gourgou Bourgade, Thierry Conroy
Publikováno v: PLoS ONE, Vol 12, Iss 9, p e0183288 (2017)
Hohla et al. suggested that female gender could positively predict response to FOLFIRINOX in patients with advanced pancreatic cancer. In this study, we explored the response to the FOLFIRINOX regimen by gender within the trial PRODIGE4/ACCORD 11.Dat
Externí odkaz: https://doaj.org/article/8906c293b1784ab59afcc545943783b3
Zobrazit plný text záznamu
2
EORTC QLQ-C30 Descriptive Analysis with the qlqc30 Command
Autor: Caroline Bascoul-Mollevi, David Azria, Florence Castan, Sophie Gourgou-Bourgade
Publikováno v: The Stata Journal: Promoting communications on statistics and Stata. 15:1060-1074
Health-related quality of life is often an endpoint in oncology clinical trials. The European Organization for Research and Treatment of Cancer (EORTC) developed the cancer-specific quality of life questionnaire (QLQ-C30), which includes five functio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::adb2a2e58c572621513865b37adcc351
https://doi.org/10.1177/1536867x1501500407
Zobrazit plný text záznamu
3
A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort
Autor: Cindy Canivet, Sophie Gourgou-Bourgade, Bertrand Napoléon, Laurent Palazzo, Nicolas Flori, Pierre Guibert, Guillaume Piessen, Dominique Farges-Bancel, Jean-François Seitz, Eric Assenat, Véronique Vendrely, Stéphanie Truant, Geoffroy Vanbiervliet, Philippe Berthelémy, Stéphane Garcia, Anne Gomez-Brouchet, Louis Buscail, Barbara Bournet, The BACAP Consortium
Publikováno v: BMC Cancer
BMC Cancer, BioMed Central, 2018, 18 (1), pp.986. ⟨10.1186/s12885-018-4906-4⟩
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
International audience; BACKGROUND: The prognosis for pancreatic cancer remains poor despite diagnostic advances and treatments with new chemotherapeutic regimens. The five year survival rate remains below 3%. Consequently, there is an urgent need fo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99b988f89209cfd1a71642127f152d13
https://doi.org/10.1186/s12885-018-4906-4
Zobrazit plný text záznamu
4
Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial
Autor: Emmanuel Chamorey, Jean-Pierre Gerard, Guy de Laroche, K. Benezery, Sophie Gourgou-Bourgade, Marc-André Mahé, Valérie Boige, Beata Juzyna
Publikováno v: Radiotherapy and Oncology. 115:246-252
Background During the ACCORD 12 randomized trial, an evaluation of the clinical tumor response was prospectively performed after neoadjuvant chemoradiotherapy. The correlations between clinical complete response and patient characteristics and treatm
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80c55cc6fb4e8ce8d575268089abc4fe
https://doi.org/10.1016/j.radonc.2015.04.003
Zobrazit plný text záznamu
5
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial
Autor: Thierry Conroy, Marta Jarlier, Aurélien Lambert, Sophie Gourgou Bourgade
Publikováno v: PLoS ONE
PLoS ONE, Vol 12, Iss 9, p e0183288 (2017)
Background Hohla et al. suggested that female gender could positively predict response to FOLFIRINOX in patients with advanced pancreatic cancer. In this study, we explored the response to the FOLFIRINOX regimen by gender within the trial PRODIGE4/AC
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1115cfcad3d079454dcaff7976f6b1
http://europepmc.org/articles/PMC5606928
Zobrazit plný text záznamu
6
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)
Autor: Manfred B. Lutz, Roberto Labianca, Patrick Pessaux, Bert A. Bonsing, Benoist Chibaudel, David Malka, Claudio Bassi, Sophie Gourgou-Bourgade, Geertjan van Tienhoven, Pascal Hammel, Carine Bellera, Laeticia Dahan, Jean-Luc Van Laethem, Daniela Aust, Emmanuel Chamorey, Jean Robert Delpero, Josep Tabernero, Adelaide Dousseau, Teresa Macarulla, Franck Bonnetain, Julien Taieb, Karin Haustermans, Laurence Collette, Thomas Aparicio, François Lacaine, John P. Neoptolemos, Simone Mathoulin-Pélissier, Bengt Glimelius, Thierry Conroy, Paula Ghaneh, Alain Sauvanet, Erich Gerber, Christos Dervenis, Aurélien Latouche, Murielle Mauer, Michel Ducreux, Valérie Jooste, Virginie Berger, Jocelyn Gal, Alain Hendlisz, Aimery de Gramont, Emmanuel Mitry
Publikováno v: European Journal of Cancer
European Journal of Cancer, Elsevier, 2014, 50 (17), pp.2983-2993. ⟨10.1016/j.ejca.2014.07.011⟩
European Journal of Cancer, Elsevier, 2014, 50 (17), pp.2983-2993. 〈10.1016/j.ejca.2014.07.011〉
European Journal of Cancer, 2014, 50 (17), pp.2983-2993. ⟨10.1016/j.ejca.2014.07.011⟩
European Journal of Cancer, 50(17), 2983-2993
International audience; BACKGROUND:Using potential surrogate end-points for overall survival (OS) such as Disease-Free- (DFS) or Progression-Free Survival (PFS) is increasingly common in randomised controlled trials (RCTs). However, end-points are to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0107770bc5e54216c1633117525092a
https://doi.org/10.1016/j.ejca.2014.07.011
Zobrazit plný text záznamu
7
Adapted physical activity and diet (APAD) during adjuvant breast cancer therapy: Design and implementation of a prospective randomized controlled trial
Autor: Grégory Ninot, Hélène Sancho-Garnier, Sophie Gourgou-Bourgade, Jean-Pierre Bleuse, Pierre Senesse, Silene Launay, Florence Cousson-Gélie, Marion Carayol, C. Janiszewski, Gilles Romieu, Chakib Sari, William Jacot
Publikováno v: Contemporary Clinical Trials. 36:531-543
Exercise practice and appropriate nutrition have been advanced as non pharmacological supportive care to reduce side effects related to cancer and its treatment, but large sample-sized randomized controlled trials are needed to confirm such results.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccc1cb1b0a35dffc6e0c7302874872c0
https://doi.org/10.1016/j.cct.2013.09.016
Zobrazit plný text záznamu
9
An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma
Autor: Julien Péron, Pascal Roy, Thierry Conroy, Brice Ozenne, Françoise Desseigne, Trevor Stanbury, Laurent Roche, Sophie Gourgou-Bourgade, Marc Ychou, Marc Buyse
Publikováno v: Oncotarget
Oncotarget, 2016, 7, pp.82953-28960. ⟨10.18632/oncotarget.12761⟩
Oncotarget, Impact journals, 2016, 7, pp.82953-28960. ⟨10.18632/oncotarget.12761⟩
Background We sought to assess the benefit-risk balance of FOLFIRINOX versus gemcitabine in patients with metastatic pancreatic adenocarcinoma. Methods We used generalized pairwise comparisons. This statistical method permits the simultaneous analysi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d950eb93387e09bc1e5f9a5e45cccb07
https://univ-lyon1.hal.science/hal-02053624
Zobrazit plný text záznamu
10
Phase II Trial of Dose Dense Docetaxel Followed by FEC100 as Neoadjuvant Chemotherapy in Patients With Operable Breast Cancer
Autor: Pierre-Emmanuel Colombo, Marian Gutowski, Frédéric Bibeau, William Jacot, Gilles Romieu, Jean-Pierre Bleuse, Andrew Kramar, Sophie Gourgou-Bourgade
Publikováno v: American Journal of Clinical Oncology. 33:544-549
Objectives: The aim of this study was to evaluate the efficacy and safety profile of 4 dose-dense cycles of docetaxel followed by 3 cycles of FEC100 neoadjuvant chemotherapy in patients with operable advanced breast cancer. Methods: Women were treate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9147a75d207e679db8ddb5f8edc3333e
https://doi.org/10.1097/coc.0b013e3181bead47
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje